BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 1468165)

  • 1. Effects of indomethacin and misoprostol on renal function in healthy volunteers.
    Wilkie ME; Davies GR; Marsh FP; Rampton DS
    Clin Nephrol; 1992 Dec; 38(6):334-7. PubMed ID: 1468165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporine nephrotoxicity in rheumatoid arthritis: no effect of short term misoprostol treatment.
    Boers M; Bensen WG; Ludwin D; Goldsmith CH; Tugwell P
    J Rheumatol; 1992 Apr; 19(4):534-7. PubMed ID: 1593573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dose-dependent effect of misoprostol on indomethacin-induced renal dysfunction in well compensated cirrhosis.
    Wong F; Massie D; Hsu P; Dudley F
    Am J Gastroenterol; 1995 Sep; 90(9):1465-70. PubMed ID: 7661171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of prostaglandin synthesis inhibition on glomerular filtration rate in renal transplant recipients.
    Marín C; Herrera J; Manzanares J; Rodríguez-Iturbe B
    Clin Nephrol; 1992 Dec; 38(6):329-33. PubMed ID: 1468164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of metronidazole and misoprostol on indomethacin-induced changes in intestinal permeability.
    Davies GR; Wilkie ME; Rampton DS
    Dig Dis Sci; 1993 Mar; 38(3):417-25. PubMed ID: 8444070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Misoprostol effects on diclofenac-induced cardiorenal changes in salt-sensitive patients with hypertension: the MEDIC Study.
    Munger MA; Gardner SF; Ateshkadi A; Rabetoy GM; Barri YM; Stoddard GJ; Cheung AK;
    Pharmacotherapy; 2008 Jul; 28(7):834-42. PubMed ID: 18576898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of prostaglandins and nitric oxide on the renal effects of angiotensin II in the anaesthetized rat.
    Clayton JS; Clark KL; Johns EJ; Drew GM
    Br J Pharmacol; 1998 Aug; 124(7):1467-74. PubMed ID: 9723960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Monitoring renal function in patients treated with cytostatics].
    Hartlev LB; Rotbøl CB; Bluhme H; Palshof T; Rehling M
    Ugeskr Laeger; 2008 Nov; 170(45):3664-7. PubMed ID: 18986617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
    Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA
    Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of indomethacin misoprostol on GFR.
    Simpson LO
    Clin Nephrol; 1993 Jul; 40(1):62. PubMed ID: 8358877
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of indomethacin on renal function in man.
    Baber N; Halliday L; Littler T; Orme M; Sibeon RG; Chan K
    Scand J Rheumatol; 1980; 9(1):52-4. PubMed ID: 7375871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of the kidney function in patients with rheumatoid arthritis: plasma cystatin C versus 51Cr-EDTA clearance.
    Karstila K; Harmoinen AP; Lehtimäki TJ; Korpela MM; Mustonen JT; Saha HH
    Nephron Clin Pract; 2008; 108(4):c284-90. PubMed ID: 18434750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental studies comparing iohexol and 51Cr-EDTA for glomerular filtration rate measurements.
    Lundqvist S; Hietala SO; Karp K
    Acta Radiol; 1995 Jan; 36(1):58-63. PubMed ID: 7833170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of misoprostol on indomethacin-induced renal dysfunction in well-compensated cirrhosis.
    Wong F; Massie D; Hsu P; Dudley F
    J Hepatol; 1995 Jul; 23(1):1-7. PubMed ID: 8530800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of misoprostol on indomethacin induced renal dysfunction in elderly patients.
    Nesher G; Sonnenblick M; Dwolatzky T
    J Rheumatol; 1995 Apr; 22(4):713-6. PubMed ID: 7791169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimization of indomethacin-induced reduction in renal function by misoprostol.
    Weir MR; Klassen DK; Hall PS; Schubert C; Voss TE; Stromatt SC; Brown JA
    J Clin Pharmacol; 1991 Aug; 31(8):729-35. PubMed ID: 1908864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromium-51-EDTA clearance in adults with a single-plasma sample.
    Mårtensson J; Groth S; Rehling M; Gref M
    J Nucl Med; 1998 Dec; 39(12):2131-7. PubMed ID: 9867156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absorption, retention and urinary excretion of chromium-51 in rats pretreated with indomethacin and dosed with dimethylprostaglandin E2, misoprostol or prostacyclin.
    Kamath SM; Stoecker BJ; Davis-Whitenack ML; Smith MM; Adeleye BO; Sangiah S
    J Nutr; 1997 Mar; 127(3):478-82. PubMed ID: 9082033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum cystatin C as an endogenous marker of renal function in patients with mild to moderate impairment of kidney function.
    Hojs R; Bevc S; Ekart R; Gorenjak M; Puklavec L
    Nephrol Dial Transplant; 2006 Jul; 21(7):1855-62. PubMed ID: 16524933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Correlation between four-hour creatinine clearance and 51Cr-EDTA test].
    Peréz E; Ugarte C; Durruty P; Soto MC; Ayca V; Sotomayor G; Soledad Barría M
    Rev Med Chil; 1995 May; 123(5):600-4. PubMed ID: 8525206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.